MedMira EBITDA vs. Current Valuation

MIR Stock  CAD 0.08  0.00  0.00%   
Based on the key profitability measurements obtained from MedMira's financial statements, MedMira may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess MedMira's ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-1.8 M
Current Value
-1.9 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, MedMira's Price To Sales Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to climb to 1,455 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 2.11 in 2024. At this time, MedMira's Accumulated Other Comprehensive Income is fairly stable compared to the past year. Income Quality is likely to climb to 0.70 in 2024, whereas Net Loss is likely to drop (3.2 M) in 2024.
For MedMira profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MedMira to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MedMira utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MedMira's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MedMira over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between MedMira's value and its price as these two are different measures arrived at by different means. Investors typically determine if MedMira is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MedMira's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MedMira Current Valuation vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining MedMira's current stock value. Our valuation model uses many indicators to compare MedMira value to that of its competitors to determine the firm's financial worth.
MedMira is considered to be number one stock in ebitda category among its peers. It also is rated top company in current valuation category among its peers . MedMira reported EBITDA of (1.81 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedMira's earnings, one of the primary drivers of an investment's value.

MedMira Current Valuation vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

MedMira

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(1.58 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

MedMira

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
58.57 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

MedMira Current Valuation vs Competition

MedMira is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 3.97 Billion. MedMira claims roughly 58.57 Million in current valuation contributing just under 2% to equities under Health Care industry.

MedMira Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in MedMira, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MedMira will eventually generate negative long term returns. The profitability progress is the general direction of MedMira's change in net profit over the period of time. It can combine multiple indicators of MedMira, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income16.8 M17.6 M
Operating Income-2.2 M-2.3 M
Net Loss-3.1 M-3.2 M
Income Tax Expense138.8 K131.8 K
Income Before Tax-3.1 M-3.2 M
Total Other Income Expense Net-658.2 K-625.3 K
Net Loss-3.1 M-3.2 M
Net Loss-2.1 M-2.2 M
Net Interest Income-807.8 K-848.2 K
Change To Netincome-11.2 K-10.7 K
Income Quality 0.54  0.70 
Net Income Per E B T 0.90  1.11 

MedMira Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on MedMira. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MedMira position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MedMira's important profitability drivers and their relationship over time.

Use MedMira in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MedMira position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedMira will appreciate offsetting losses from the drop in the long position's value.

MedMira Pair Trading

MedMira Pair Trading Analysis

The ability to find closely correlated positions to MedMira could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MedMira when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MedMira - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MedMira to buy it.
The correlation of MedMira is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MedMira moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MedMira moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MedMira can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your MedMira position

In addition to having MedMira in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel
Apparel Theme
Companies manufacturing textile accessories and apparel products. The Apparel theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for MedMira Stock Analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.